Literature DB >> 31845169

Initiation of a fixed- dose four- factor prothrombin complex concentrate protocol.

Ajay Kumar Mishra1, Kamal Kant Sahu2, Ahmad Daniyal Siddiqui3, Susan V George2.   

Abstract

Year:  2020        PMID： 31845169     DOI： 10.1007/s11239-019-02020-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  7 in total

1.  A spontaneous rectus sheath hematoma.

Authors:  Kamal Kant Sahu; Sandhya Maradana; Ajay Mishra; Iryna Chastain
Journal:  Intern Emerg Med       Date:  2018-08-29       Impact factor: 3.397

2.  Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol.

Authors:  L Fuh; J N Goldstein; B D Hayes
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

3.  Pharmacist Presence Decreases Time to Prothrombin Complex Concentrate in Emergency Department Patients with Life-Threatening Bleeding and Urgent Procedures.

Authors:  Dalila Masic; Daniel Colon Hidalgo; Shannon Kuhrau; Whitney Chaney; Megan A Rech
Journal:  J Emerg Med       Date:  2019-08-22       Impact factor: 1.484

4.  Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.

Authors:  Shigeki Kushimoto; Toshio Fukuoka; Akio Kimura; Kazunori Toyoda; Andres Brainsky; Amy Harman; Thomas Chung; Masahiro Yasaka
Journal:  Int J Hematol       Date:  2017-08-16       Impact factor: 2.490

5.  Letter to the Editor Regarding "Management of spinal emergencies in patients on direct oral anticoagulants".

Authors:  Ajay Kumar Mishra; Kamal Kant Sahu; Nirmal Prasad Basaula; Amos Lal
Journal:  World Neurosurg       Date:  2019-11-19       Impact factor: 2.104

6.  Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.

Authors:  M Marcos-Jubilar; J A García Erce; N Martínez-Calle; J A Páramo; A Martínez Virto; M Quintana-Díaz
Journal:  Transfus Med       Date:  2019-07-25       Impact factor: 2.019

7.  Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Authors:  Ravi Sarode; Truman J Milling; Majed A Refaai; Antoinette Mangione; Astrid Schneider; Billie L Durn; Joshua N Goldstein
Journal:  Circulation       Date:  2013-08-09       Impact factor: 29.690
  7 in total
  2 in total

1.  Stroke Symptoms in a Patient on 4-Factor Prothrombin Complex.

Authors:  Ajay Kumar Mishra; Kamal Kant Sahu; Amos Lal
Journal:  Hosp Pharm       Date:  2020-03-02

2.  Factors contributing to poor outcome in patients on warfarin receiving 4-factor prothrombin complex concentrate in critically ill.

Authors:  Ajay Kumar Mishra; Kamal Kant Sahu; Amos Lal; Susan V George
Journal:  Acta Biomed       Date:  2021-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.